These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31650)

  • 21. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.
    McTavish SF; Cowen PJ; Sharp T
    Psychopharmacology (Berl); 1999 Jan; 141(2):182-8. PubMed ID: 9952043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat.
    Hedner T; Lundborg P
    Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 31. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
    Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
    Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 33. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H; Carlsson A
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine metabolism during bicuculline-induced epileptic seizures in the rat.
    Calderini G; Carlsson A; Nordström CH
    Brain Res; 1978 Nov; 157(2):295-302. PubMed ID: 309780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis.
    Penington NJ; Fox AP
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1160-5. PubMed ID: 8014859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of single and multiple dose LSD on endogenous levels of brain tyrosine and catecholamines.
    Smith RC; Boggan WO; Freedman DX
    Psychopharmacologia; 1975 Jun; 42(3):271-6. PubMed ID: 1161985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.
    Watts VJ; Lawler CP; Fox DR; Neve KA; Nichols DE; Mailman RB
    Psychopharmacology (Berl); 1995 Apr; 118(4):401-9. PubMed ID: 7568626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
    White FJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):365-79. PubMed ID: 3952127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.